- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/20 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
Patent holdings for IPC class C07D 209/20
Total number of patents in this class: 362
10-year publication summary
|
19
|
24
|
33
|
23
|
15
|
40
|
21
|
26
|
19
|
14
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2162 |
9 |
| On Target Laboratories, LLC | 31 |
9 |
| The Johns Hopkins University | 5887 |
7 |
| Massachusetts Institute of Technology | 10254 |
6 |
| Apotex Technologies Inc. | 16 |
6 |
| Cybin UK Ltd | 43 |
6 |
| California Institute of Technology | 4037 |
5 |
| BELLUS Health Inc. | 10 |
5 |
| Heidelberg Pharma Research GmbH | 85 |
5 |
| Enveric Biosciences Canada Inc. | 65 |
5 |
| The Trustees of Columbia University in the City of New York | 3648 |
4 |
| Ajinomoto Co., Inc. | 2281 |
4 |
| Purdue Research Foundation | 3921 |
4 |
| Korea Research Institute of Bioscience and Biotechnology | 1062 |
4 |
| Ramot at Tel-Aviv University Ltd. | 1549 |
4 |
| Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. | 6 |
4 |
| NovaTarg, Inc. | 5 |
4 |
| The General Hospital Corporation | 4871 |
3 |
| Duke University | 3182 |
3 |
| Asahi Kasei Kabushiki Kaisha | 2834 |
3 |
| Other owners | 262 |